Certificate of Analysis
Each batch of Tesamorelin undergoes rigorous third-party testing to ensure purity and identity verification. View the full lab report below.
Tesamorelin
Tesamorelin is a growth hormone-releasing hormone (GHRH) analog. This synthetic peptide contains 44 amino acids and is used in metabolic research applications.
99%+
10mg
Bundle & Save
Order before 2 PM EST, ships the same day. Fast, fully tracked, and sent in discreet, secure packaging. Free shipping on orders over $99.
Purity Guarantee. If independent third-party testing doesn't confirm our stated purity standards, you get a full refund plus a free replacement.
For Research Use Only
Intended for in-vitro research only. Not for human consumption. Must be 21+.
Specifications
Certificate of Analysis
Each batch of Tesamorelin undergoes rigorous third-party testing to ensure purity and identity verification. View the full lab report below.
Research background
Tesamorelin: A Research Overview of the Stabilized GHRH Analogue
How a single trans-3-hexenoyl group turns native GHRH into a longer-lived analogue, what the phase 3 and liver-fat trials actually found, what preclinical work showed, and how to handle tesamorelin in the lab.
Buy it as a stack
This compound is part of a curated set. Same vials, same testing, lower total.
Overview
Biochemical Characteristics
The trans-3-hexenoic acid modification at the N-terminus enhances metabolic stability and prolongs biological activity compared to native GHRH in experimental models.
Research Applications
Pathway / Mechanistic Context
Preclinical Research Summary
Form & Analytical Testing
Mechanisms of Action
GHRH Receptor Agonism - Potent full agonist at the pituitary GHRH receptor (GHRH-R)
GH Axis Stimulation - Triggers robust, physiological growth hormone release patterns
Visceral Fat Reduction - Selective effects on trunk and visceral adiposity
IGF-1 Modulation - Secondary elevation of insulin-like growth factor-1 through GH stimulation
Research Applications
1Lipodystrophy Research
Primary research application in visceral adipose tissue studies.
Key Research Findings
- Reduced visceral adipose tissue in published clinical studies of HIV-associated lipodystrophy
- Improved trunk fat-to-limb fat ratio in published clinical studies
- Did not significantly change subcutaneous fat depots in those studies
- Reduces hepatic lipid content in experimental settings
2Growth Hormone Axis Studies
Research on pituitary function and GH secretion dynamics.
Key Research Findings
- Produces robust, pulsatile GH release patterns
- Maintains physiological feedback mechanisms
- Elevates IGF-1 levels through GH-mediated hepatic production
- Useful for studying somatotroph function and regulation
3Metabolic Function Research
Studies on metabolic parameters and body composition.
Key Research Findings
- Improves lipid profiles in research models
- Affects glucose metabolism through GH/IGF-1 axis
- Modulates adipokine secretion patterns
- Influences protein metabolism and lean body mass
Supporting Research & Bibliography
The following peer-reviewed publications support the research applications described above. References are provided for informational purposes to assist researchers in their literature review.
Total references: 4
Note: The information provided is for research reference only. It summarizes published in-vitro, animal and, where cited, human clinical studies of the compound; findings from those studies are not claims about this product. This product is intended for laboratory research purposes only. Not for human or veterinary use.
Research Use Only: This product is intended for laboratory research purposes only. Not for human or veterinary use. By purchasing, you confirm that you are a qualified researcher and will use this product in accordance with all applicable regulations.